Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Chimeric monoclonal antibody against GD2

EU orphan designation number: EU/3/12/1062   
Active ingredient: Chimeric monoclonal antibody against GD2
Indication: Treatment of neuroblastoma
Sponsor: APEIRON Biologics AG
Campus Vienna Biocenter 5, A-1030 Wien, Österreich

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2012 Centralised Orphan - Designation EMA/OD/112/12 (2012)8195 of 08/11/2012